iRhythm Technologies Upgraded by Analysts

Summary

iRhythm Technologies (NASDAQ: IRTC) received a ‘moderate buy’ consensus rating from ten brokerage firms, including one ‘hold’ and nine ‘buy’ ratings. The average one-year target price is $138.60. Recent analyst reports include Robert W. Baird and Citi Group upgrading their target prices to $150.00 and $167.00, respectively. The stock opened at $139.22, with a 52-week range of $55.92 to $157.13. The company reported quarterly revenue of $158.68 million but missed earnings per share expectations. Insiders sold 5,356 shares over the past ninety days.Market Beat

Impact Analysis

The event is classified at the company level, involving iRhythm Technologies. The analyst upgrades reflect positive sentiment and confidence in the company’s future performance. The first-order effects include a potential increase in stock price due to improved investor perception and increased demand for shares. The second-order effects could involve heightened interest from institutional investors and potential strategic partnerships or expansions. Investment opportunities arise in purchasing iRhythm Technologies shares, with risks including potential volatility due to previous insider selling and ongoing securities litigation.Market Beat+ 2